NCT07923201Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Evaluating Functional Outcomes and Clinical Feasibility of the Zeen Mobility Device in Outpatient Rehabilitation
Source: ClinicalTrials.gov · Last updated 6 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether the Zeen Mobility Device can improve mobility and function during outpatient rehabilitation for adults with mobility impairments. The study will also evaluate the safety of the device and how easy it is for participants and therapists to use during routine therapy. The main questions it aims to answer are: * Does using the Zeen Mobility Device improve walking, standing, transfers, and daily function compared with a participant's usual mobility device? * Can the Zeen Mobility Device be safely incorporated into outpatient rehabilitation? * How satisfied are participants and therapists with using the device during therapy? Researchers will compare participants' performance using the Zeen Mobility Device with their performance using their usual mobility device, such as a walker or wheelchair. Participants will serve as their own comparison group. Participants will: * Complete a baseline assessment before starting the study, a midpoint assessment after 4 treatment sessions, and a final assessment after 8 treatment sessions. * Attend 8 outpatient physical therapy sessions that include use of the Zeen Mobility Device. * Use the Zeen Mobility Device for at least 15 minutes during each study visit for balance, mobility, walking, transfer, or standing activities selected by their therapist. * Complete mobility and functional tests using both the Zeen Mobility Device and their usual mobility device at each assessment visit. * Provide feedback about their experience using the device while researchers monitor safety and any device-related problems.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 19 Oct 2026
- Start date
- 2 Nov 2026
- Primary completion date
- 5 Mar 2027
- Lead sponsor
- Casa Colina Hospital and Centers for Healthcare
- Diseases
- Stroke, Parkinson disease, Multiple sclerosis
- NCT number
- NCT07923201
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 2 Nov 2026 to the primary completion date, 5 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment
Other
- Medical instability that would preclude participation
- Inability to safely participate in mobility assessments
Who the study is looking for
- Be 18 years of age or older
- Be enrolled in outpatient PT and/or OT
- Demonstrate mobility limitations appropriate for Zeen use
- Meet the following functional thresholds:
- 6MWT: 800-1800 feet
- 10MWT: 0.4-1.3 m/s
- Grip strength ≥1 pound in at least one hand
- Knee extension strength ≥ MMT grade 3/5
- Be capable of providing informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Casa Colina Hospital and Centers for Healthcare Coordinator of this site? Confirm its status | Pomona | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.